Posts tagged “GSK”
As WRAL TechWire has reported extensively over the past few months, IBM keeps adding to the capabilities of its Watson supercomputer services. Now, drug giant GSK is incorporating Watson interactive artificial intelligence into an advertising campaign for its cough and cold advertising.
GlaxoSmithKline has agreed to pay $20 million to resolve U.S. regulators' allegations that the pharmaceutical giant's China operations bribed officials to boost drug sales. Plus: Read the SEC summary of the case.
GlaxoSmithKline picks Emma Walmsley, a female executive of its management team, to replace CEO Andrew Witty when he retires early next year. Plus: Read her bio, watch video about the news.
GlaxoSmithKline takes home the honor as the top business on Fortune's annual "Change the World" list. Two other tech/biotech companies with a big North Carolina presence also are recognized: Novozymes and IBM.
Mayne Pharma's $50M GSK deal; UNC-CH opioid drug project; SAS targets heat, disease; RTI's $2M biofuels deal
In today's wrapup of tech and life science headlines from around the Triangle region: Mayne Pharma spends $50 million to acquire some GSK dermatology assets; UNC-CH researchers help develop an opioid drug candidate from scratch; SAS works with an Arizona county to fight heat and disease; and RTI International lands a $2M-plus biofuels contract.
One of Google's sister companies will team up with pharmaceuticals firm GlaxoSmithKline to form a joint venture that aims to develop tiny implants that can tap nerves and change their electronic signals as a way of treating chronic illnesses.